CAROLINE AUER: Open Payments
NPI 1174276331 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$134 in 7 payments from 5 companies in 2025. Trend: 2023 $158 · 2024 $359 · 2025 $134
Food & beverage: $134
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $51 |
| Amgen Inc. | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| PFIZER INC. | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
Products named: LEQVIO, Kerendia, VYNDAQEL, CAMZYOS.
Industry payments across AL — which companies pay providers there.
